Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus Results From the CANVAS Program

被引：143

作者：

Figtree, Gemma A. ^{[1
,2
,3
]}

Radholm, Karin ^{[3
,4
]}

Barrett, Terrance D. ^{[5
]}

Perkovic, Vlado ^{[3
]}

Mahaffey, Kenneth W. ^{[6
]}

de Zeeuw, Dick ^{[7
]}

Fulcher, Greg ^{[1
,2
]}

Matthews, David R. ^{[8
,9
]}

Shaw, Wayne ^{[5
]}

Neal, Bruce ^{[3
,10
,11
]}

机构：

[1] Royal North Shore Hosp, Kolling Inst, St Leonards, NSW, Australia

[2] Univ Sydney, Sydney, NSW, Australia

[3] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia

[4] Linkoping Univ, Cty Council Ostergotland, Dept Local Care West,Fac Hlth Sci, Div Community Med,Primary Care,Dept Med & Hlth Sc, Linkoping, Sweden

[5] Janssen Res & Dev LLC, Raritan, NJ USA

[6] Stanford Univ, Sch Med, Dept Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA

[7] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands

[8] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England

[9] Univ Oxford, Harris Manchester Coll, Oxford, England

[10] Univ New South Wales, Fac Med, Sydney, NSW, Australia

[11] Imperial Coll London, London, England

来源：

CIRCULATION | 2019年 / 139卷 / 22期

关键词：

canagliflozin; heart failure; randomized trial; SGLT2; inhibitor; type 2 diabetes mellitus;

D O I：

10.1161/CIRCULATIONAHA.119.040057

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：2591 / 2593

页数：3

共 4 条

[1]

Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry [J].

Cavender, Matthew A. ;

Steg, Ph Gabriel ;

Smith, Sidney C., Jr. ;

Eagle, Kim ;

Ohman, E. Magnus ;

Goto, Shinya ;

Kuder, Julia ;

Im, Kyungah ;

Wilson, Peter W. F. ;

Bhatt, Deepak L. .

CIRCULATION, 2015, 132 (10) :923-931

[2]

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes [J].

Neal, Bruce ;

Perkovic, Vlado ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Erondu, Ngozi ;

Shaw, Wayne ;

Law, Gordon ;

Desai, Mehul ;

Matthews, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (07) :644-657

[3]

Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program [J].

Radholm, Karin ;

Figtree, Gemma ;

Perkovic, Vlado ;

Solomon, Scott D. ;

Mahaffey, Kenneth W. ;

de Zeeuw, Dick ;

Fulcher, Greg ;

Barrett, Terrance D. ;

Shaw, Wayne ;

Desai, Mehul ;

Matthews, David R. ;

Neal, Bruce .

CIRCULATION, 2018, 138 (05) :458-468

[4]

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes [J].

Zinman, Bernard ;

Wanner, Christoph ;

Lachin, John M. ;

Fitchett, David ;

Bluhmki, Erich ;

Hantel, Stefan ;

Mattheus, Michaela ;

Devins, Theresa ;

Johansen, Odd Erik ;

Woerle, Hans J. ;

Broedl, Uli C. ;

Inzucchi, Silvio E. ;

Aizenberg, D. ;

Ulla, M. ;

Waitman, J. ;

De Loredo, L. ;

Farias, J. ;

Fideleff, H. ;

Lagrutta, M. ;

Maldonado, N. ;

Colombo, H. ;

Ferre Pacora, F. ;

Wasserman, A. ;

Maffei, L. ;

Lehman, R. ;

Selvanayagam, J. ;

d'Emden, M. ;

Fasching, P. ;

Paulweber, B. ;

Toplak, H. ;

Luger, A. ;

Drexel, H. ;

Prager, R. ;

Schnack, C. ;

Schernthaner, G. ;

Fliesser-Goerzer, E. ;

Kaser, S. ;

Scheen, A. ;

Van Gaal, L. ;

Hollanders, G. ;

Kockaerts, Y. ;

Capiau, L. ;

Chachati, A. ;

Persu, A. ;

Hermans, M. ;

Vantroyen, D. ;

Vercammen, C. ;

Van de Borne, P. ;

Mathieu, C. ;

Benhalima, K. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (22) :2117-2128

← 1 →